Clinical Trial Update: Clinical Investigation Into Inhaled Treprostinil Sodium in Patients With Severe Pulmonary Arterial Hypertension (PAH) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial investigated inhaled treprostinil sodium for severe pulmonary arterial hypertension; results were posted after completion in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension
• Pulmonary Hypertension

Drugs mentioned

• Treprostinil (treprostinil)

Snippet

Sponsor: United Therapeutics | Conditions: Pulmonary Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2013-08-12